1. A multicenter, real‐world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus. Issue 3 (2nd June 2022) Authors: Dittus, Christopher; Grover, Natalie; Sethi, Tarsheen; Cohen, Jonathon B.; Voloschin, Alfredo; Rabadey, Janhvi; Tan, Xianming; Beaven, Anne; Park, Steven I. Journal: EJHaem Issue: Volume 3:Issue 3(2022) Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A retrospective study on prephase therapy prior to definitive multiagent chemotherapy in aggressive lymphomas. Issue 6 (11th May 2020) Authors: Malpica, Luis; Mufuka, Bolanle; Galeotti, Jonathan; Tan, Xianming; Grover, Natalie; Clark, Stephen M.; Beaven, Anne; Muss, Hyman; Dittus, Christopher Journal: Leukemia & lymphoma Issue: Volume 61:Issue 6(2020) Page Start: 1508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durable Control of Mycosis Fungoides after Sepsis: "Coley's Toxin?" Case Report and Review of the Literature. (4th August 2019) Authors: Heyman, Benjamin; Kelsey, Chris R.; Beaven, Anne Other Names: Nagasawa Masayuki Academic Editor. Journal: Case reports in hematology Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Novel ZAP-70-Related Immunodeficiency Presenting with Epstein–Barr Virus Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis. (21st June 2021) Authors: Forster, Moriah; Moran, Timothy; Beaven, Anne; Voorhees, Timothy Other Names: Pignata Claudio Academic Editor. Journal: Case reports in immunology Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Outcomes following splenectomy in patients with myeloid neoplasms. Issue 4 (9th December 2014) Authors: Rialon, Kristy L.; Speicher, Paul J.; Ceppa, Eugene P.; Rendell, Victoria R.; Vaslef, Steven N.; Beaven, Anne; Tyler, Douglas S.; Blazer, Dan G. Journal: Journal of surgical oncology Issue: Volume 111:Issue 4(2015:Mar. 15) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma. Issue 12 (December 2013) Authors: Brander, Danielle; Rizzieri, David; Gockerman, Jon; Diehl, Louis; Shea, Thomas Charles; Decastro, Carlos; Moore, Joseph O.; Beaven, Anne Journal: Leukemia & lymphoma Issue: Volume 54:Issue 12(2013:Dec.) Page Start: 2627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma. (26th November 2021) Authors: Islam, Prioty; Rizzieri, David; Lin, Chenyu; de Castro, Carlos; Diehl, Louis; Li, Zhiguo; Moore, Joseph; Morris, Tod; Beaven, Anne Journal: Cancer investigation Issue: Volume 39:Number 10(2021) Page Start: 871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗